Free Trial

AlTi Global Inc. Sells 6,532 Shares of CME Group Inc. (NASDAQ:CME)

CME Group logo with Finance background

AlTi Global Inc. trimmed its position in CME Group Inc. (NASDAQ:CME - Free Report) by 10.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 55,637 shares of the financial services provider's stock after selling 6,532 shares during the period. AlTi Global Inc.'s holdings in CME Group were worth $13,043,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of CME. Vanguard Group Inc. boosted its stake in CME Group by 1.0% during the fourth quarter. Vanguard Group Inc. now owns 34,243,090 shares of the financial services provider's stock valued at $7,952,273,000 after buying an additional 326,623 shares during the last quarter. Geode Capital Management LLC grew its stake in CME Group by 1.3% during the 4th quarter. Geode Capital Management LLC now owns 8,389,442 shares of the financial services provider's stock worth $1,946,717,000 after buying an additional 104,697 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in shares of CME Group by 89.9% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider's stock valued at $1,923,047,000 after acquiring an additional 3,921,278 shares during the period. Norges Bank purchased a new stake in CME Group in the fourth quarter valued at approximately $1,107,389,000. Finally, FIL Ltd grew its position in CME Group by 1.5% during the 4th quarter. FIL Ltd now owns 4,081,391 shares of the financial services provider's stock worth $947,821,000 after purchasing an additional 61,908 shares during the period. 87.75% of the stock is currently owned by institutional investors.

Insider Activity

In other news, Director Dennis Suskind sold 1,000 shares of the company's stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $271.28, for a total value of $271,280.00. Following the transaction, the director now owns 2,915 shares of the company's stock, valued at approximately $790,781.20. This represents a 25.54 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Derek Sammann sold 4,650 shares of the firm's stock in a transaction on Monday, May 5th. The stock was sold at an average price of $280.61, for a total value of $1,304,836.50. Following the completion of the transaction, the insider now owns 8,336 shares in the company, valued at $2,339,164.96. The trade was a 35.81 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 34,726 shares of company stock worth $8,975,813 over the last three months. Corporate insiders own 0.30% of the company's stock.

CME Group Price Performance

NASDAQ:CME traded down $1.34 during mid-day trading on Thursday, hitting $283.48. The company's stock had a trading volume of 784,691 shares, compared to its average volume of 2,153,039. The stock has a fifty day moving average of $263.32 and a 200-day moving average of $244.76. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The company has a market capitalization of $102.15 billion, a price-to-earnings ratio of 29.32, a P/E/G ratio of 6.76 and a beta of 0.45. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $287.50.

CME Group (NASDAQ:CME - Get Free Report) last announced its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, topping the consensus estimate of $2.61 by $0.19. CME Group had a return on equity of 13.62% and a net margin of 57.52%. The company had revenue of $1.64 billion for the quarter, compared to analysts' expectations of $1.56 billion. During the same quarter in the prior year, the business earned $2.50 earnings per share. The business's revenue for the quarter was up 10.4% on a year-over-year basis. As a group, equities analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.76%. CME Group's dividend payout ratio (DPR) is currently 50.30%.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the stock. Royal Bank of Canada restated a "sector perform" rating and set a $269.00 price target on shares of CME Group in a research report on Thursday, April 3rd. Keefe, Bruyette & Woods boosted their target price on CME Group from $265.00 to $273.00 and gave the company a "market perform" rating in a report on Thursday, April 24th. Erste Group Bank upgraded CME Group to a "strong-buy" rating in a research report on Monday, March 17th. Raymond James upgraded CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price objective on the stock in a research report on Monday, March 10th. Finally, Barclays increased their price target on CME Group from $279.00 to $283.00 and gave the stock an "equal weight" rating in a research note on Wednesday, April 23rd. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $256.80.

Get Our Latest Stock Analysis on CME Group

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 5 Stocks for June: AI Picks That Aren’t NVIDIA
This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines